Cognitive therapy in relapse prevention in depression

International Journal of Neuropsychopharmacology

Volumn 10, Issue 1, 2007, Pages 131-136

  Paykel, Eugene S ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Cognitive therapy; Depression; Relapse

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; FLUOXETINE; MOOD STABILIZER; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

CLINICAL EFFECTIVENESS; CLINICAL PRACTICE; CLINICAL TRIAL; COGNITIVE THERAPY; COST EFFECTIVENESS ANALYSIS; DEPRESSION; DRUG EFFICACY; DRUG TREATMENT FAILURE; FOLLOW UP; HEALTH CARE COST; HUMAN; MAINTENANCE THERAPY; MEDICAL RESEARCH; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROPHYLAXIS; PSYCHOPHARMACOTHERAPY; RECURRENCE RISK; RECURRENT DISEASE; RELAPSE; REMISSION; REVIEW; SYMPTOM; TREATMENT OUTCOME; TREATMENT WITHDRAWAL;

ANTIDEPRESSIVE AGENTS; COGNITIVE THERAPY; COMBINED MODALITY THERAPY; DEPRESSION; HUMANS; RECURRENCE; TREATMENT OUTCOME;

EID: 33846270686     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S1461145706006912     Document Type: Review

References (36)

1. Beck AT (2005). The current state of cognitive therapy: a 40-year retrospective. Archives of General Psychiatry 62, 953-959.
2. Bockting CL, Schene AH, Spinhoven P, Koeter MW, Wouters LF, Huyser J, Kamphuis JH (2005). Preventing relapse/recurrence in recurrent depression with cognitive therapy: a randomized controlled trial. Journal of Consulting and Clinical Psychology 7, 647-657.
3. Blackburn IM, Eunson KM, Bishop S (1986). A two year naturalistic follow up of depressed patients treated with cognitive therapy, pharmacotherapy and a combination of both. Journal of Affective Disorders 10, 67-75.
4. Churchill R, Hunot V, Corney R, Knapp M, McGuire H, Tylee A, Wessely S (2001). A systematic review of controlled trials of the effectiveness and cost-effectiveness of brief psychological treatments for depression. Health Technology Assessment 5, no. 35.
5. Evans MD, Hollon SD, De Rubeis RJ, Piasecki JM, Grove WM, Garvey MJ, Tuason VB (1992). Differential relapse following cognitive therapy and pharmacotherapy for depression. Archives of General Psychiatry 49, 802-808.
6. Fava GA, Grandi S, Zielezny M, Canestrari R, Morphy MA (1994). Cognitive behavioural treatment of residual symptoms in primary major depressive disorder. American Journal of Psychiatry 151, 1295-1299.
7. Fava GA, Grandi S, Zielezny M, Rafanelli C, Canestrari R (1996). Four-year outcome for cognitive behavioural treatment of residual symptoms in major depression. American Journal of Psychiatry 153, 945-947.
8. Fava GA, Rafanelli C, Grandi S, Canestrari R, Morphy MA (1998a). Six year outcome for cognitive behavioural treatment of residual symptoms in major depression. American Journal of Psychiatry 155, 1443-1445.
9. Fava GA, Rafanelli C, Grandi S, Conti S, Belluardo P (1998b). Prevention of recurrent depression with cognitive behavioural therapy: preliminary findings. Archives of General Psychiatry 55, 816-820.
10. Fava G, Ruini C, Finos L, Conti S, Grandi S (2004). Six-year outcome of cognitive behaviour therapy for prevention of recurrent depression. American Journal of Psychiatry 161, 1872-1876.
11. Hollon SD, DeRubeis RJ, Shelton RC, Amsterdam JD, Salomon RM, O'Reardon JP, Lovett ML, Young PR, Haman KL, Freeman BB, Gallop R (2005). Prevention of relapse following cognitive therapy vs medications in moderate to severe depression. Archives of General Psychiatry 62, 417-422.
12. Jarrett RB, Kraft D, Doyle J, Foster BM, Eaves CG, Silver PC (2001). Preventing recurrent depression using cognitive therapy with and without a continuation phase: a randomised clinical trial. Archives of General Psychiatry 58, 381-388.
13. Keller MB, Klerman GL, Lavori PW, Coryell W, Endicott J, Taylor J (1984). Long-term outcome of episodes of major depression: clinical and public health significance. Journal of the American Medical Association 252, 788-792.
14. Kennedy N, Abbott R, Paykel ES (2003). Remission and recurrence of depression in the maintenance era: long-term outcome in a Cambridge cohort. Psychological Medicine 33, 827-838.
15. Kennedy N, Abbott R, Paykel ES (2004). Longitudinal syndromal and sub-syndromal symptoms after severe depression: 10-year follow-up study. British Journal of Psychiatry 184, 330-336.
16. Kiloh LG, Andrews GA, Neilson M (1988). The long-term outcome of depressive illness. British Journal of Psychiatry 153, 752-757.
17. Kovacs M, Rush AJ, Beck AT, Hollon SD (1981). Depressed outpatients treated with cognitive therapy or pharmacotherapy. Archives of General Psychiatry 38, 33-41.
18. Lee AS, Murray RM (1988). The long-term outcome of Maudsley depressives. British Journal of Psychiatry 153, 741-751.
19. Ma SH, Teasdale JD (2004). Mindfulness-based cognitive therapy for depression: replication and exploration of differential relapse prevention effects. Journal of Consulting and Clinical Psychology 72, 31-40.
20. Miller IW, Norman WG, Keitner GI (1989). Cognitive-behavioral treatment of depresssed inpatients: six- and twelve-month follow-up. American Journal of Psychiatry 146, 1274-1279.
21. Mueller TI, Leon AC, Keller MB, Solomon DA, Endicott J, Coryell W, Warshaw M, Maser JD (1999). Recurrence after recovery from major depressive disorder during 15 years of observational follow-up. American Journal of Psychiatry 156, 1000-1006.
22. Paykel ES, Hart D, Priest RG (1998). Changes in public attitudes to depression during the Defeat Depression Campaign. British Journal of Psychiatry 173, 519-522.
23. Paykel ES, Ramana R, Cooper Z, Hayhurst, H, Kerr J, Barocka A (1995). Residual symptoms after partial remission: an important outcome in depression. Psychological Medicine 25, 1171-1180.
24. Paykel ES, Scott J, Cornwall PL, Abbott R, Crane C, Pope M, Johnson AL (2005). Duration of relapse prevention after cognitive therapy in residual depression: a follow-up of controlled trial. Psychological Medicine 35, 59-68.
25. Paykel ES, Scott J, Teasdale JD, Johnson AL, Garland A, Moore R, Jenaway A, Cornwall PL, Hayhurst H, Abbott R, Pope M (1999). Prevention of relapse in residual depression by cognitive therapy. A controlled trial. Archives of General Psychiatry 56, 829-835.
26. Proudfoot J, Goldberg D, Mann A, Everitt B, Marks I, Gray JA (2003). Computerized, interactive, multimedia cognitive-behavioural program for anxiety and depression in general practice. Psychological Medicine 33, 217-227.
27. Ramana R, Paykel ES, Cooper Z, Hayhurst, H, Saxty, M, Surtees PG (1995). Remission and relapse in major depression: a two-year prospective follow-up study. Psychological Medicine 25, 1161-1170.
28. Ramana R, Paykel ES, Melzer D, Mehta MA, Surtees PG (2003). Aftercare of depressed inpatients: service delivery and unmet needs. Social Psychiatry and Psychiatric Epidemiology 38, 109-115.
29. Ramana R, Paykel ES, Surtees PG, Melzer D, Mehta M (1999). Medication received by patients with depression following the acute episode: adequacy and relation to outcome. British Journal of Psychiatry 174, 128-134.
30. Scott J, Palmer S, Paykel E, Teasdale J, Hayhurst H (2003). Use of cognitive therapy for relapse prevention in chronic depression: cost effectiveness study. British Journal of Psychiatry 182, 221-227.
31. Scott J, Teasdale JD, Paykel ES, Johnson AL, Abbott R, Hayhurst H, Moore R, Garland A (2000). Effects of cognitive therapy on psychological symptoms and social functioning in residual depression. British Journal of Psychiatry 177, 440-446.
32. Shea MT, Elkin I, Linber S, Sotsky S, Watkins J, Collins J, Pilkonis P, Beckham E, Glass D, Dolan R, Parioff M (1992). Course of depressive symptoms over follow-up. Archives of General Psychiatry 49, 782-787.
33. Simons AD, Murphy GE, Levine JL, Wetzel RD (1986). Cognitive therapy and pharmacotherapy of depression: sustained improvement over one year. Archives of General Psychiatry 43, 43-50.
34. Surtees PG, Barkley C (1994). Future imperfect: the long-term outcome of depression. British Journal of Psychiatry 164, 327-341.
35. Teasdale JD, Scott J, Moore RG, Hayhurst H, Pope M, Paykel ES (2001). How does cognitive therapy prevent relapse in residual depression? Evidence from a controlled trial. Journal of Consulting and Clinical Psychology 69, 347-357.
36. Teasdale JD, Segal ZV, Williams JM, Ridgeway VA, Soulsby JM, Lau MA (2000). Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy. Journal of Consulting and Clinical Psychology 68, 615-623.